2018 - IHE

Norlin J, Althin R, Schmitt-Egenolf M & Persson U An outcome-based payment model for biologic agents in psoriasis Lund, Sweden: IHE Report 2018:2
Norrlid H, Norlin J, Holmstrup H, Malmberg I, Sartorius K, Thormann H, Jemec G B.E. and Ragnarson Tennvall G Patient-Reported Outcomes in Topical Field Treatment of Actinic Keratosis in Swedish and Danish Patients Journal of Dermatological Treatment, 2018;29(1):68-73
DOI: https://doi.org/10.1080/09546634.2017.1329514
Hjalte F, Calara PS, Blaxhult A, Helleberg M, Wallace K & Lindgren P Excess costs of non-infectious comorbidities among people living with HIV – estimates from Denmark and Sweden AIDS Care. 2018 May; 30(0): 1090-1098
DOI: https://doi.org/10.1080/09540121.2018.1476661
Alexandersson N, Rosell L, Wihl J, Ohlsson B, Steen Carlsson K, Nilbert M. Determinants of variable resource use for multidisciplinary team meetings in cancer care Acta Oncol. 2018 May; 57(5): 675-680
DOI: 10.1080/0284186X.2017.1400682
PMID: 29199517
Palmer A, Si L, Tew M, Hua X, Willis M, Asseburg C, McEwan P, Leal J, Gray A, Foos V, Lamotte M, Feenstra T, O’Connor P, Brandle M, Smolen H, Gahn J, Valentine W, Pollock R, Breeze P, Brennan A, Pollard D, Ye W, Herman W, Isaman D, Kuo S, Laiteerapong N, Tran-Duy A and Clarke P Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge Value in Health 2018 June; 21(6): 724-731
DOI: https://doi.org/10.1016/j.jval.2018.02.002
Persson U & Norlin JM Multi-indication and Combination Pricing and Reimbursement of Pharmaceuticals: Opportunities for Improved Health Care through Faster Uptake of New Innovations Appl Health Econ Health Policy 2018 Apr;16(2):157-165
DOI:10.1007/s40258-018-0377-7
Löfvendahl S, Jöud A, Petersson IF, Theander E, Svensson Å and Steen Carlsson K Income disparities in healthcare use remain after controlling for healthcare need. Evidence from Swedish register data on psoriasis and psoriatic arthritis The European Journal of Health Economic, 2018 Apr; 19(3): 447-462
DOI: 10.1007/s10198-017-0895-5
Holm E, Steen Carlsson K, Lövdahl S, Lail A, Abshire T, Berntorp E. Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network Haemophilia 2018 Jul; 24(4): 628-633 Apr 6.
DOI: 10.1111/hae.13473. PMID: 29626372
Neslusan C, Teschemaker A, Willis M, Johansen P and V Lien Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States Diabetes Therapy, 2018. Published Online: 06 February 2018
DOI: https://doi.org/10.1007/s13300-018-0371-y
Ericsson Å, Glah D, Lorenzi M, Jansen JP & Fridhammar A Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes PloS One, 2018;13(2):e0191953.
DOI: https://doi.org/10.1371/journal.pone.0191953

Back »Next »